One-and-a-half years after Ajay Piramal sold the formulations business of the group flagship Piramal Healthcare to US-based Abbott Laboratories in a multi-billion-dollar deal, he seems to be on an ...
TO READ THE FULL STORY
- Definitive news, exclusives, analyses and videos
Exclusive reporting, expert analysis and commentary on PE/VC/M&A deals & dealmakers
Daily, weekly and monthly curated newsletters on the deal ecosystem in India
Breaking news alerts
Participation in marquee events at concessional rates
Comprehensive | Accurate | Unbiased | Impeccably sourced